-+ 0.00%
-+ 0.00%
-+ 0.00%

Canaccord Genuity Maintains Buy on LifeStance Health Gr, Raises Price Target to $10

Benzinga·02/26/2026 19:58:00
Listen to the news
Canaccord Genuity analyst Richard Close maintains LifeStance Health Gr (NASDAQ:LFST) with a Buy and raises the price target from $9 to $10.